Thymosin beta4: a new molecular target for antitumor strategies.
Goldstein
Allan L
AL
D000199:Actins / Q000096:biosynthesis / Q000378:metabolism*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002468:Cell Physiological Phenomena / Q000187:drug effects; D002471:Cell Transformation, Neoplastic; D006801:Humans; D008297:Male; D008546:Melanoma, Experimental / Q000378:metabolism; D009362:Neoplasm Metastasis; D009389:Neovascularization, Pathologic / Q000378:metabolism* / Q000517:prevention & control; D011471:Prostatic Neoplasms / Q000378:metabolism; D013947:Thymosin / Q000378:metabolism* / Q000494:pharmacology; D015854:Up-Regulation; D000099201:Thymosin beta(4)
D000199:Actins; D000970:Antineoplastic Agents; D013947:Thymosin; D000099201:Thymosin beta(4)